At a glance
- Originator Alter
- Class Antihypotensives; Antimigraines; Dihydropyridines; Thiazoles; Vascular disorder therapies
- Mechanism of Action Calcium channel agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Glaucoma; Hypotension; Nose disorders
Most Recent Events
- 11 Jun 2001 No-Development-Reported for Glaucoma in Spain (Ophthalmic)
- 11 Jun 2001 No-Development-Reported for Hypotension in Spain (IV)
- 11 Jun 2001 No-Development-Reported for Nose disorders in Spain (Intranasal)